Submit your abstract and present your research

Abstract submission is closed. Only abstracts for symposia agreed with the scientific committee can be submitted.

1. Check the congress topics

Reproductive Neuroendocrinology, FSH and LH receptors, Hyperprolactinemia, GnRH analogues and antagonist, Steroids and steroid receptors signaling mechanisms, Biological actions of progestins, Androgens and hyperandrogenisms, Primary and secondary amenorrhea, Polycystic ovary syndrome, Insulin resistance, Obesity, metabolic syndrome, Pediatric and adolescent endocrinology, Thyroid diseases, Endocrine disorders and women s health, Endocrine disruptors, Selective steroid receptor modulators, Regulation of the HPG axis,
New compounds for contraception, Non-contraceptive benefits of contraceptives, Male contraception, Emergency contraception, Medical and surgical abortion, Intrauterine contraceptives, Contraception and adolescents, Contraception and perimenopause, Therapeutic uses of HC, Long lasting contraception,
Embryo implantation and development, Stem cells and human reproduction, Mechanisms of follicle selection and development, Reproduction, the Immune system and oxidative stress, The infertile couple, Techniques in MAP, Ovulation induction, Ovarian hyperstimulation, Endometriosis and assisted reproduction, The anovulatory patient, Endocrine disorders and medically assisted procreation, Adnexal diseases and MAP, Fertility preservation, Autologue and heterologue donation, MAP and ethics, MAP in premature ovarian insufficiency, Time Laps, PGD/PGS
Recurrent abortion, Extra-uterine pregnancy, Prenatal diagnosis, Prenatal medicine, The placenta and the fetal membranes, The thyroid and pregnancy, Immunological disorders and pregnancy, Endocrine disorders in pregnancy, Neurodegenerative disorders in pregnancy, Insulin resistance and obstetric diseases, Obesity and fetal and maternal risks, Pregnancy and lifestyle, Preterm labor and delivery, Gestational hypertension, pre-eclampsia and eclampsia, Gestational Diabetes Mellitus, Normal and abnormal intrauterine growth, Infectious diseases and pregnancy, Twin and multiple pregnancies, Labor induction, Caesarean Section: pro and con, Fetal origins of adult diseases, Postpartum management of high risk pregnancies
Stem cells in gynecology, Angiogenesis and gynecological diseases, Puberty and adolescent gynecology, Female sexual function and dysfunction, Sexually transmitted diseases, Hormones and gynecological disorders, Endometrial regulation, Abnormal uterine bleeding, Pelvic pain, Endometrial hyperplasia, Endometriosis: genetics and hormones, Medical treatments for endometriosis, Uterine myomas, medical and surgical management, Clinical management of adnexal cysts, Vulvar and vaginal lesions, Adenomyosis
Steroid hormones and ageing, Neurotoxicity, neuronal survival and hormone protection, The climacteric syndrome, Menopause, HRT and CVD, Menopause, HRT and cancers, Menopause, HRT and neurodegenerative diseases, Postmenopausal osteoporosis, Bisphosphonates, PTH and the boneforming agents, Selective estrogen receptor modulators SERM’s, Progesterone, progestins SPRM’s, Androgen therapy, Bio-identical treatments, Non-hormonal treatments for climacteric women, Sexual health and dysfunction, Phytoestrogens, Plant extrats and steroid receptors.
Genes and gynecological cancers, Hormones and gynecological cancers, Stem cells and gynecological malignancies, Proteomics for cancer diagnosis and treatment, Screenings and for gynecological cancers, HPV and HPV vaccines, Border-line and pre-tumoral lesions, Clinical management of gynecological cancers, Conservative approaches to gynecological cancers, New concepts in radio/chemotherapy, Hormonal therapies for gynecological cancers, Pregnancy and cancer
Breast development and function, Hormones and the breast, Benign breast diseases, contraception and HRT, Breast carcinogenesis, Hormones, breast cancer proliferation and metastasis, New prognostic and predictive factors, Anti-estrogens, SERMs and aromatase inhibitors, Oncological and aesthetic breast surgery, Breast cancer and pregnancy.

Vaginal approaches to pelvic diseases,
Urinary incontinence,
New techniques for pelvic floor defects correction,
Laparoscopic treatment of pelvic masses,
Laparoscopy, endometriosis and reproduction,
New treatments of uterine myomas,
Sentinel node biopsy in gynecological cancers,
Oncological applications of aparoscopy,
Robotic surgery in gynecology,
Multidisciplinary approach to the pelvic floor

Ultrasound in gynecology and obstetrics, Interventional ultrasound techniques, Hysteroscopy, Colposcopy, Laparoscopy

2. Scholarships

The ISGE offers scholarships for those who present an abstract. There are 3 levels of scholarships:

  • Full Congress Package (FCP)

    DEADLINE TO APPLY: 1 February 2022

    This scholarship includes: Congress registration, Hotel accommodation, the Scholarship Course
    Requirements: Applicants must meet all the following criteria: be a student, trainee or post-doctoral; be under the age of 35; have one or more abstracts accepted for oral or poster presentation; be the primary author of the accepted abstract.
    Limits: There will only be 50 FCP Scholarships available and they will be assigned upon selection.
  • Free Congress Registrations (FCR)

    DEADLINE TO APPLY: 8 March 2022

    This scholarship includes: Congress registration and the Scholarship Course
    Applicants must meet all the following criteria: be a trainee; have one or more abstracts accepted for oral or poster presentation; be the primary author of the accepted abstract.
  • Reduced registration fee

    DEADLINE TO APPLY: 8 March 2022

    This scholarship includes: a reduced registration fee
    Requirements: Applicants must meet all the following criteria: have one or more abstracts accepted for oral or poster presentation; be the primary author of the accepted abstract.

3. Compose and Submit

How to prepare the abstract

  • Abstracts should be structured into the following sections if applicable:  Context – Objective – Methods – Patient(s) – Intervention(s) – Main Outcome Measure(s) – Result(s) – Conclusions.
  • The abstract cannot be longer than 2500 characters including spaces, and must be plain text. It is not possible to include tables and images, but you may insert data in the text of the abstract.
  • Each person is allowed to submit a maximum of two abstracts on the congress’ topics as presenting author: one oral presentation and one poster or, alternatively, two posters. There is no limit to the number of abstracts submitted as co-author
  • Abstracts can only be submitted using the on-line form. Abstracts submitted via email are automatically discarded.
  • Once submitted and accepted, abstract cannot be modified in any of its parts (authors, content and title).


  • Abstract’s submission deadline for oral presentations is 15 February 2022.
  • Abstract’s submission deadline for posters is 8 March 2022.
  • Presenting authors of accepted abstracts  will be notified within 13 March 2022 whether their abstract is accepted.

4. Once approved, complete your congress registration!

Speakers whose abstracts have been accepted are  eligible for a reduced registration fee of 350€!

You must register for the Congress within 28 March 2022 otherwise your abstract will be excluded from the Scientific Program.

5. Present your abstract in Florence

The accepted abstracts will be divided into Oral Presentation Sessions and Poster Session.

The Oral Presentation Sessions will be held both online and on-site. All abstracts presented on-site will be made available in the virtual congress.

What if I cannot travel? The Scientific Committee will evaluate the possibility to present remotely or to pre-record the registration for those who are unable to travel due to covid-19 restrictions (economic travelling problems will not be taken into consideration).

The Poster session will be organized in Florence; all the poster presenters will be also requested to upload their poster for the virtual congress.

Rules for presentation is available in the Account area of the abstract submitter.